Umban, Shirlyn A.

HRN: 29-08-33  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/24/2026
MUPIROCIN 2%, 15G (TUBE)
06/24/2026
06/28/2026
INTRANASAL
4%
BID
Necritzing
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Skin & Soft Tissue    Compliance to guidelines: Compliant To Guidelines